Total results found = 24
Introducing Ophteis® FR Pro with sorbitol – for Free Radical Scavenging (FRS)
cataract surgery|endothelial protection|endothelium|FR Pro|Lacey|ophthalmic viscoelastic devices|osmolarity|OVD Clinical Article Rayner IOL
Arshinoff|Bowyer|cataract surgery|dispersive|endothelial protection|endothelium|Lacey|methylvisc|ophthalmic viscoelastic devices|osmolarity|OVD|Sandeman Congress Presentation Lacey J, Bowyer C, Sandeman S, Arshinoff S
Professor Steve Arshinoff discusses the importance of viscoelastic in cataract surgery at Rayner's Ophteis Acquisitio...
Rayner will be hosting a very special ESCRS event to mark the recent acquisition of the Ophteis OVD portfolio.
Professor Steve Arshinoff and Rayner CEO Tim Clover will make a short speech before inviting guests to join the celebration w...
DECEMBER 22, 2021 – Worthing, United Kingdom. Rayner, a leading UK-based ophthalmic company focused on optimising visual outcomes for surgeons and their patients, is delighted to announce the appointment of
DECEMBER 02, 2021 – Worthing, United Kingdom. Rayner Surgical Group (‘Rayner’) and Omeros Corporation (‘Omeros’) are delighted to announce the transfer of Omeros’ ophthalmology assets, including OmidriaTM, to Rayner. This will enable the
NOVEMBER 24, 2021 – Worthing, United Kingdom. Rayner, a leading ophthalmology company focused on optimising visual outcomes for patients and surgeons, today announced the appointment of Dr Rob Nadler to the
AUGUST 04, 2021 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract and refractive surgery, announced today that it has achieved the milestone figure of 1,000
JUNE 18, 2021 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract and refractive surgery, announced today that it has acquired Surgicon Healthcare Pvt Limited in
New York, USA, May 17, 2021 – RayOne Spheric, a fully-preloaded monofocal IOL, has received FDA approval. This achievement marks Rayner’s third FDA approval in under three years within its
Takeaways: Rayner’s fully preloaded RayOne Aspheric IOL has received NMPA approval for sale in China. RayOne Aspheric will be showcased at the 21st CSCRS from 3-5 June 2021 in Dalian. RayOne Aspheric offers a premium
Worthing, UK, 3 May 2021 – With the global rollout of the RayOne EMV™ intraocular lens to markets around the world, Rayner announces today an exciting new campaign intended to
Auffarth|cataract surgery|dispersive|endothelial protection|endothelium|Khoramnia|Merz|methylvisc|Munro|ophthalmic viscoelastic devices|osmolarity|OVD|Son|Yildirim Peer Review Publication Yildirim TM, Auffarth GU, Son H-S, Khoramnia R, Munro DJ, Merz PR
Rayner is proud to have supplied Dr Woodruff with Rayner C-flex Aspheric Monofocal IOLs and OphteisBio 3% OVD for his recent visit to Ethiopia as Visiting Professor & Mentor in Paediatric Ophthalmology, Gondar University Hospital 25th March...
For those of you who have visited the Rayner website over the last few days, you will have noticed we’re now offering a very different online experience; one that we believe is clearer and more user-friendly.
It’s al...
The new-look Rayner booth -- designed specifically with RayOne® demos in mind -- was inundated with traffic. Surgeons clamored to experience the highly anticipated, fully preloaded IOL injection system at the recent XXXIV Congres...
Dr Steve Arshinoff, Mr Sathish Srinivasan and Mr Manyank Nanavaty complete the panel of speakers for the Rayner-sponsored satellite symposium ‘Outcome Excellence in Cataract Surgery’ at the XXXIV ESCRS in Copenhagen, 10-14 Sep...
Rayner is an independent British business and one of the world’s top manufacturers of intraocular lenses (IOLs) for the global market. Last year alone we produced more than 800,000 IOLs.
Part of our business philosophy from day on...
Rayner’s growth strategy continues as the company announced today that the Egyptian Ministry of Health has approved the following IOLs for sale in Egypt:
Reflecting the needs of our global customer, Rayner is pleased to announce that the French and Spanish translations of the company website www.rayner.com are now live.
Open New Year Letter from CEO. The past year has been a transformative one for Rayner as we transition to a company exclusively focused on IOLs and cataract surgery. The disposal of our retail business and move to new pur...
Arshinoff|cataract surgery|endothelial protection|endothelium|Jafari|ophthalmic viscoelastic devices|osmolarity|OVD Peer Review Publication Arshinoff SA, Jafari M.
Augustin|Dick|ophthalmic viscoelastic devices|osmolarity|OVD|Pfeiffer|Rayvisc Peer Review Publication Dick HB, Augustin AJ, Pfeiffer N.